GlassScriptPhysician profile
Jerry Jomi
NPI 1013366509
$10,742.46
in general payments reported to CMS, 2019-2025
43 companies · $2,221 in 2025
The $2,221 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $594 · 2021: $113 · 2022: $195 · 2023: $2,780 · 2024: $4,840 · 2025: $2,221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,913 · Education: $2,670 · Travel and Lodging: $2,258.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,913.08 |
| Education | $2,669.98 |
| Travel and Lodging | $2,257.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,600.87 | 2024-2025 | |
| Medical Device Business Services, INC. | $1,380.71 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $1,018.59 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Actelion Pharmaceuticals US, INC. | $544.88 | 2023-2025 | Uptravi, Opsumit, Opsynvi |
| United Therapeutics Corporation | $402.23 | 2023-2025 | Tyvaso, Tyvaso |
| Ethicon INC. | $281.38 | 2023 | Monarch Platform |
| Glaxosmithkline, LLC. | $245.81 | 2024-2025 | Nucala, Trelegy Ellipta |
| Axsome Therapeutics, INC. | $176.28 | 2023-2025 | Sunosi |
| Inspire Medical Systems, INC. | $169.55 | 2025 | Inspire |
| Jazz Pharmaceuticals INC. | $162.41 | 2023-2025 | |
| Galvanize Therapeutics, INC | $159.63 | 2025 | Aliya System |
| Avadel Cns Pharmaceuticals, LLC | $140.59 | 2024-2025 | Lumryz |
| Mylan Specialty L.P. | $139.43 | 2022-2024 | Yupelri |
| Grifols USA, LLC | $135.94 | 2023-2025 | Prolastin-C Liquid, Xembify |
| Genzyme Corporation | $135.13 | 2023-2025 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $130.33 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Takeda Pharmaceuticals U.S.A., INC. | $129.24 | 2023-2025 | Glassia |
| Janssen Pharmaceuticals, INC | $125.00 | 2019 | |
| Akcea Therapeutics, INC. | $121.32 | 2019 | |
| Merck Sharp & Dohme LLC | $118.36 | 2024-2025 | Winrevair |
| Abbvie INC. | $117.75 | 2019 | |
| Csl Behring | $112.72 | 2021 | |
| Ani Pharmaceuticals, INC. | $111.03 | 2024-2025 | Purified Cortrophin Gel |
| Amarin Pharma, INC. | $105.00 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $97.28 | 2023-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.96 | 2022 | |
| Genentech USA, INC. | $83.55 | 2025 | Xolair |
| Amgen INC. | $76.13 | 2024-2025 | Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.24 | 2023-2025 | Stiolto Respimat, Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $72.71 | 2024-2025 | Dupixent |
| Viatris Specialty LLC | $71.57 | 2025 | Yupelri |
| Philips North America LLC | $58.41 | 2024-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Verona Pharma, INC. | $55.99 | 2025 | Ohtuvayre |
| Harmony Biosciences LLC | $52.19 | 2023-2025 | Wakix |
| Idorsia Pharmaceuticals US INC | $47.01 | 2023-2024 | Quviviq |
| Inogen, INC. | $40.69 | 2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Novartis Pharmaceuticals Corporation | $33.31 | 2025 | |
| Mallinckrodt Hospital Products INC. | $23.37 | 2025 | Acthar |
| Lilly USA, LLC | $20.89 | 2025 | Zepbound |
| Pfizer INC. | $20.31 | 2024 | |
| Hikma Pharmaceuticals USA | $19.04 | 2023 | Ryaltris |
| Insmed, INC. | $17.63 | 2025 | Arikayce |
| Erbe USA INC | $17.00 | 2023 | Erbe Vio |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jerry Jomi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.